ClinVar Miner

Submissions for variant NM_206933.4(USH2A):c.653T>A (p.Val218Glu) (rs397518026)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000041890 SCV000065586 pathogenic Rare genetic deafness 2016-08-09 criteria provided, single submitter clinical testing The p.Val218Glu variant in USH2A has been reported in at least 8 individuals wit h Usher syndrome, all of whom carried a second, pathogenic USH2A variant on the other allele (Leroy 2001, Cremers 2007, Baux 2007, Herrera 2008, Bonnet 2011, Gl ockle 2013, Besnard 2014). This variant has also been identified in 5/66590 Euro pean chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadins; dbSNP rs397518026). Although it has been seen in the general populat ion, its frequency is low enough to be consistent with a recessive carrier frequ ency. In summary, this variant meets criteria to be classified as pathogenic for Usher syndrome in an autosomal recessive manner based upon its occurrence in tr ans with known pathogenic USH2A variants in multiple affected individuals.
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000408647 SCV000484497 uncertain significance not provided 2015-09-24 criteria provided, single submitter clinical testing
Invitae RCV000408647 SCV000963510 pathogenic not provided 2020-10-07 criteria provided, single submitter clinical testing This sequence change replaces valine with glutamic acid at codon 218 of the USH2A protein (p.Val218Glu). The valine residue is highly conserved and there is a moderate physicochemical difference between valine and glutamic acid. This variant is present in population databases (rs397518026, ExAC 0.008%). This variant has been observed in individual(s) with Usher syndrome (PMID: 11311042, 28559085, 21569298, 16963483). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 48564). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: Deleterious; PolyPhen-2: Probably Damaging; Align-GVGD: Class C0). For these reasons, this variant has been classified as Pathogenic.
Blueprint Genetics RCV001075204 SCV001240818 pathogenic Retinal dystrophy 2018-11-15 criteria provided, single submitter clinical testing
CeGaT Praxis fuer Humangenetik Tuebingen RCV000408647 SCV001250066 pathogenic not provided 2021-02-01 criteria provided, single submitter clinical testing
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000408647 SCV001447913 pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
Broad Institute Rare Disease Group, Broad Institute RCV000504825 SCV001950401 likely pathogenic Retinitis pigmentosa 2021-04-01 criteria provided, single submitter curation The p.Val218Glu variant in USH2A was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab ( Through a review of available evidence we were able to apply the following criteria: PM2, PP3, PM3-S. Based on this evidence we have classified this variant as Likely Pathogenic. If you have any questions about the classification please reach out to the Pierce Lab.
NIHR Bioresource Rare Diseases, University of Cambridge RCV000504825 SCV000598821 likely pathogenic Retinitis pigmentosa 2015-01-01 no assertion criteria provided research
Counsyl RCV000675152 SCV000800758 pathogenic Retinitis pigmentosa 39 2017-04-20 no assertion criteria provided clinical testing
Clinical Genetics,Academic Medical Center RCV000408647 SCV001923955 likely pathogenic not provided no assertion criteria provided clinical testing
Human Genetics - Radboudumc,Radboudumc RCV000408647 SCV001959678 likely pathogenic not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.